
Semaglutide effects on weight management
Share
Semaglutide has emerged as a significant contender in the world of weight management. It was originally designed to regulate blood sugar in diabetes patients, but its potential for weight management in non-diabetic individuals is what’s truly game-changing.
For those who have struggled to shed extra weight, Semaglutide offers renewed hope as it operates by targeting appetite regulation and promoting a sensation of fullness. Semaglutide achieves this by targeting a specific brain region known as GLP-1 receptors, which play a pivotal role in regulating appetite and food intake.¹ This combination makes it a potential game-changer in the battle against obesity.
What is semaglutide?
Semaglutide was initially formulated to address diabetes, but its usefulness has evolved beyond this. It’s emerged as a facilitator of weight management, and it has created a paradigm shift in the treatment of obesity.¹
Designed as a glucagon-like peptide-1 (GLP-1) receptor agonist, Semaglutide was created to regulate blood sugar levels in individuals with diabetes.¹ However, its ability to mimic the effects of GLP-1, a hormone that plays a crucial role in blood sugar regulation and appetite control, is what also makes it a useful tool for chronic weight management.
Semaglutide effectively taps into the brain's appetite regulation system, signaling a sense of fullness and satisfaction. As a result, individuals find themselves naturally inclined to consume fewer calories, paving the way for sustainable lifestyle changes.
Appetite regulation is a key component of Semaglutide’s usefulness in weight management. By curbing cravings and reducing the urge to overeat, it provides a powerful tool for those striving to achieve lasting weight changes. Curbing cravings is about more than just suppression; it acts as a catalyst for behavioral changes, allowing individuals to adopt healthier eating habits and, subsequently, witness enduring transformations in their overall lifestyle.
Semaglutide can help people break the cycle of excessive calorie intake, which is a common challenge in weight management. This medication empowers individuals by aligning their biological signals with healthier lifestyle choices. It can be a powerful tool in developing a more balanced and controlled approach to eating.
Unlike quick-fix solutions that may offer temporary results, Semaglutide focuses on fostering a lasting shift in behavior. By addressing the root cause of overeating — imbalanced hunger signals — it becomes a reliable ally in the journey towards a healthier weight and a more sustainable, balanced lifestyle.
How effective is semaglutide for weight loss?
Semaglutide stands out as an effective weight loss option for non-diabetic people. In fact, scientific studies consistently show that when combined with a comprehensive weight management program, Semaglutide produces more significant weight loss results than relying on dietary effort and exercise alone.² This highlights the medication's unique ability to support people in building sustainable, lasting lifestyle changes.
Semaglutide's effectiveness stems from its targeted action on GLP-1 receptors in the brain, mirroring the effects of the GLP-1 hormone.³ This physiological response induces feelings of fullness and satisfaction, which is a crucial aspect of weight loss that isn’t addressed by diet and physical activity alone — the ability to control appetite and manage cravings.
While adopting a healthier lifestyle through diet and exercise is crucial for managing weight, studies have found that keeping the weight off in the long run is a challenge for many people.⁴ Clinical guidelines recommend supportive medication in these situations, especially for adults with a body-mass index (BMI) of 30 or higher, or 27 or higher for individuals who have other health issues. However, it’s important to speak to your provider about individual circumstances.²
Clinical trials further emphasize Semaglutide's potential in weight management. Study participants who took Semaglutide experienced substantial reductions in body weight, with over 50% of participants achieving weight reductions of 15% or more.² These clinically significant weight loss results underscore the medication's potential to achieve tangible and meaningful outcomes for individuals struggling to manage their weight.
Side effects
Before embarking on any new weight management program, it’s important to understand the potential for side effects. For effective weight management, Semaglutide is typically administered weekly through a self-administered subcutaneous injection. While most people will have a smooth experience with Semaglutide, some people may experience side effects. Some of the more common side effects include:⁵
-
Gastrointestinal effects: Nausea and vomiting are common side effects associated with Semaglutide. These effects are often transient and tend to diminish as the body adjusts to the treatment.
-
Fatigue: Some users may experience fatigue as a side effect of Semaglutide. Monitoring and open communication with healthcare providers can help manage and address this common response.
-
Decreased appetite: Semaglutide's influence on appetite regulation may lead to a decreased desire for food.
-
Injection site reactions: Some individuals may experience mild reactions, such as redness or discomfort, at the injection site.
Individual responses to Semaglutide can vary, and it's crucial to communicate openly with your healthcare provider about any side effects you encounter during treatment. It’s important to note that the side effects associated with Semaglutide, although common, are generally manageable.
Benefits of semaglutide
-
Potential cardiovascular improvements: Beyond potential weight loss, Semaglutide may contribute to improvements in cardiovascular health, such as reducing the risk of heart disease.⁶
-
Other potential health improvements: Studies suggest that Semaglutide may offer other health improvements, such as lower blood pressure,⁷ improved cholesterol,⁸ and reduced inflammation.⁹
-
Support for lifestyle changes: The medication complements healthy lifestyle modifications, offering a supportive tool for individuals committed to making sustainable changes.
-
Long-term maintenance: Semaglutide's effectiveness may help individuals with long-term weight maintenance, providing a potential solution for those who seek lasting results.
Please note: Ralph Wellness does not offer Ozempic® or Wegovy®, which are only available from the Novo Nordisk company. Compounded Semaglutide is a patient-specific medication created in a state Board of Pharmacy or FDA licensed compounding facility per a prescription from a licensed healthcare professional. Compounded drugs are required to exclusively use ingredients from FDA-licensed facilities, and test sterile compounds for potency, sterility, and purity. While compounded drugs are legal they do not undergo pre-market approval from the FDA as they are not made in large batches for the public, compounds are made based on specific orders from a medical professional. Because of that the dose, route of administration, safety, and efficacy may differ from commercially available, brand-name, drugs. Henry Meds exclusively works with licensed sterile compounding pharmacies in the United States.
To help you trust the information we provide, every article written by Ralph Wellness relies on peer-reviewed studies and medically-reviewed facts. We ensure that data, ideas, and figures cited are reliable, current, and accurate. Our team of medical reviewers aim to help you cut through the noise with clear and authoritative primary and secondary sources.
Nothing in this article is intended to be prescriptive or medical advice. Talk to your doctor before starting a new diet and exercise plan. Information presented is about our medically supervised weight management programs and is not an advertisement for a specific drug.
Sources
-
U.S. Food and Drug Administration. FDA approves new drug treatment for chronic weight management, first since 2014. (2021, June 4).
-
Wilding, J.P.H., et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine. (2021, March 18).
-
Collins, L. and Costello, R.A. Glucagon-Like Peptide-1 Receptor Agonists. StatPearls. (2023, January 13).
-
Hall, K.D. and Kahan, S. Maintenance of lost weight and long-term management of obesity. Med Clin North Am. (January 2018).
-
U.S. Food and Drug Administration. Highlights of Prescribing Information - Wegovy (semaglutide) injection. (July 2023).
-
Lincoff, A.M., et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. The New England Journal of Medicine. (2023, December 14).
-
Kennedy, C., et al. The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis. J Clin Med. (February 2023).
-
Kosiborod, M.N., et al. Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses. Diabetes Obes Metab. (February 2023).
-
Pan, X., et al. Semaglutide ameliorates obesity-induced cardiac inflammation and oxidative stress mediated via reduction of neutrophil Cxcl2, S100a8, and S100a9 expression. Mol Cell Biochem. (2023, June 15).
-
Wilding, J.P.H., et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism. (2022, April 19).